---
title: "Hysterectomy Linked to Higher Risk of Cardiometabolic Factors: Systematic Review & Meta-analysis"
id: "medrxiv-2-decision-for-hysterectomy-as-a-modifiable-cardiovascular-risk-factor-a"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-2-decision-for-hysterectomy-as-a-modifiable-cardiovascular-risk-factor-a"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.11.26367416v1?rss=1"
published_at: "2026-11-11T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Hysterectomy Linked to Higher Risk of Cardiometabolic Factors: Systematic Review & Meta-analysis
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-2-decision-for-hysterectomy-as-a-modifiable-cardiovascular-risk-factor-a
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.11.26367416v1?rss=1)
- **Published At:** 2026-11-11T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The authors conducted a systematic review and meta-analysis to evaluate whether **hysterectomy** is associated with new-onset atherosclerotic cardiovascular disease risk factors across multiple study designs. - Researchers searched PubMed, Cochrane Library, Embase, and ScienceDirect through March 10, 2026; 18,337 records were screened and 20 studies met inclusion criteria (11 cohort, 8 cross-sectional, 1 mixed). - Outcomes prespecified included incident **hypertension**, **diabetes**, **hyperlipidemia**, **obesity**, **metabolic syndrome**, and other metabolic effects recorded after surgery. - Meta-analyses used a generic inverse-variance random-effects model, stratified by study design and by reported effect measure (adjusted OR, adjusted HR, or RR), with narrative synthesis for non-meta-analyzable outcomes. - Pooled estimates indicated increased risks: cross-sectional ORs and cohort HRs both suggested higher rates of **hypertension** and **diabetes** after **hysterectomy**; pooled HR also showed elevated **hyperlipidemia** risk. - The pooled cross-sectional OR for **obesity** and **metabolic syndrome** were elevated; exact effect sizes and confidence intervals are reported in the source. - Study quality was assessed using the Newcastle-Ottawa Scale for cohorts and a modified tool for cross-sectional studies; study selection and extraction were performed independently with consensus resolution. - The authors recommend active cardiovascular risk assessment and follow-up for women undergoing **hysterectomy**, with particular attention to younger age at surgery as a potential subgroup of interest. - The source did not provide detailed trial-level dosing or intervention protocols (not applicable), and specific age-stratified effect estimates or long-term follow-up durations beyond study design categories were not fully reported in the abstract.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=TqsE0gqB9cS5W6L1VvLiyGRmQ3Nf_MX6TDeE8WGYf2g-1794427541.41381-1.2.1.1-TC8Nt3XSAD7HNTxsasy2zR2YnUXUwV3HDuufwcjCjhecbGBa0UYHhXDuvA7tbcF7) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.11.11.26367416v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Decision for hysterectomy as a modifiable cardiovascular risk factor: A systematic review and meta-analysis [ View ORCID Profile](http://orcid.org/0000-0003-4100-123X)DMCS Jayasundara, [ View ORCID Profile](http://orcid.org/0009-0005-3767-9541)TDKM Jayasingha, [ View ORCID Profile](http://orcid.org/0000-0001-6568-8035)IA Jayawardane, [ View ORCID Profile](http://orcid.org/0000-0003-0496-7203)S De Silva Weliange, [ View ORCID Profile](http://orcid.org/0000-0001-8879-0681)IU Ratnasekera doi: https://doi.org/10.64898/2026.11.11.26367416 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. DMCS Jayasundara 1 University of Colombo Faculty of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=DMCS%2BJayasundara%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Jayasundara%20D&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADMCS%2BJayasundara%2B) * [ORCID record for DMCS Jayasundara](http://orcid.org/0000-0003-4100-123X "Open in new tab") * For correspondence: chandana@obg.cmb.ac.lk TDKM Jayasingha 1 University of Colombo Faculty of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=TDKM%2BJayasingha%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Jayasingha%20T&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ATDKM%2BJayasingha%2B) * [ORCID record for TDKM Jayasingha](http://orcid.org/0009-0005-3767-9541 "Open in new tab") IA Jayawardane 1 University of Colombo Faculty of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=IA%2BJayawardane%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Jayawardane%20I&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AIA%2BJayawardane%2B) * [ORCID record for IA Jayawardane](http://orcid.org/0000-0001-6568-8035 "Open in new tab") S De Silva Weliange 2 University of Colombo Faculty of medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=S%2BDe%2BSilva%2BWeliange%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Weliange%20SD&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AS%2BDe%2BSilva%2BWeliange%2B) * [ORCID record for S De Silva Weliange](http://orcid.org/0000-0003-0496-7203 "Open in new tab") IU Ratnasekera 3 Sri Jayewardenepura General Hospital * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=IU%2BRatnasekera%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Ratnasekera%20I&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AIU%2BRatnasekera%2B) * [ORCID record for IU Ratnasekera](http://orcid.org/0000-0001-8879-0681 "Open in new tab") * [Abstract](https://www.medrxiv.org/content/10.64898/2026.11.11.26367416v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1342556/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.11.11.26367416v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1342556/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.11.11.26367416v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1342556/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.11.11.26367416v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1342556/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.11.11.26367416v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1342556/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.11.11.26367416v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1342556/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Objective: To describe the role of hysterectomy in modifying the major atherosclerotic cardiovascular disease risk factors. Data sources: PubMed, Cochrane Library, Embase, and ScienceDirect were searched from database inception to March 10, 2026. Study eligibility criteria: Full-text randomized controlled trials, case-control studies, cross-sectional studies, cohort studies, case series, and experimental studies reporting new-onset cardiovascular events, diabetes mellitus, hypertension, dyslipidemia, or other metabolic effects following hysterectomy were eligible. Reviews and book chapters were excluded. Study appraisal and synthesis methods: Study selection and data extraction were performed independently by multiple reviewers with conflicts resolved by consensus. Cohort study quality was assessed with the Newcastle-Ottawa Scale; a modified version assessed cross-sectional studies. Meta-analyses were performed using a generic inverse-variance random-effects model for each outcome, stratified by study design (cross-sectional versus cohort) and effect measure (adjusted odds ratio, adjusted hazard ratio, or relative risk). Narrative synthesis was performed for outcomes not meeting criteria for meta-analysis. Results: Twenty studies (11 cohort, 8 cross-sectional, 1 mixed design) were included after screening 18,337 records from four databases. Hysterectomy was associated with significantly increased risk of hypertension (cross-sectional odds ratio 1.32, 95% confidence interval 1.18–1.48; cohort hazard ratio 1.19, 95% confidence interval 1.09–1.30), diabetes (cross-sectional odds ratio 1.21, 95% confidence interval 1.11–1.32; cohort hazard ratio 1.20, 95% confidence interval 1.13–1.29), hyperlipidemia (hazard ratio 1.21, 95% confidence interval 1.13–1.29), obesity (odds ratio 1.24, 95% confidence interval 1.03–1.50), and metabolic syndrome (odds ratio 1.24, 95% confidence interval 1.08–1.44). Conclusions: Hysterectomy is associated with increased risk of hypertension, diabetes, hyperlipidemia, obesity, and metabolic syndrome, key modifiable atherosclerotic cardiovascular disease risk factors. Active cardiovascular risk assessment and follow-up may be warranted for women who undergo hysterectomy, particularly at a young age. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability All relevant data are within the manuscript and its Supporting Information files. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.11.11.26367416v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.11.09.26367646v1 "Genome-Wide Study of Early Disability Severity in Multiple Sclerosis")[Next ](https://www.medrxiv.org/content/10.64898/2026.11.10.26367718v1 "Functional connectivity of reward and cognitive control networks predicts body mass index but not binge eating disorder in women") Posted November 11, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.11.11.26367416v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/11/11/2026.11.11.26367416.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.11.11.26367416v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.11.11.26367416v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/11/11/2026.11.11.26367416.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Decision for hysterectomy as a modifiable cardiovascular risk factor: A systematic review and meta-analysis DMCS Jayasundara, TDKM Jayasingha, IA Jayawardane, S De Silva Weliange, IU Ratnasekera medRxiv 2026.11.11.26367416; doi: https://doi.org/10.64898/2026.11.11.26367416 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.11.26367416v1%26text%3DDecision%2520for%2520hysterectomy%2520as%2520a%2520modifiable%2520cardiovascular%2520risk%2520factor%253A%2520A%2520systematic%2520review%2520and%2520meta-analysis "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.11.26367416v1%26t%3DDecision%2520for%2520hysterectomy%2520as%2520a%2520modifiable%2520cardiovascular%2520risk%2520factor%253A%2520A%2520systematic%2520review%2520and%2520meta-analysis "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.11.26367416v1%26title%3DDecision%2520for%2520hysterectomy%2520as%2520a%2520modifiable%2520cardiovascular%2520risk%2520factor%253A%2520A%2520systematic%2520review%2520and%2520meta-analysis%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.11.26367416v1%26title%3DDecision%2520for%2520hysterectomy%2520as%2520a%2520modifiable%2520cardiovascular%2520risk%2520factor%253A%2520A%2520systematic%2520review%2520and%2520meta-analysis "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.11.11.26367416) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.11.11.26367416v1&count=horizontal&via=&text=Decision%20for%20hysterectomy%20as%20a%20modifiable%20cardiovascular%20risk%20factor%3A%20A%20systematic%20review%20and%20meta-analysis&counturl=www.medrxiv.org/content/10.64898/2026.11.11.26367416v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (638) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (920) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (352) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (5017) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (496) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (429) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (679) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1696) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16282) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (36) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1242) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7290) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (753) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1095) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5304) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1474) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1836) * [Hematology](https://www.medrxiv.org/collection/hematology) (599) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1383) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16501) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1203) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (701) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (157) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (754) * [Neurology](https://www.medrxiv.org/collection/neurology) (7616) * [Nursing](https://www.medrxiv.org/collection/nursing) (380) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1132) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1296) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1041) * [Oncology](https://www.medrxiv.org/collection/oncology) (3751) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1096) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (411) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (466) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (502) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (143) * [Pathology](https://www.medrxiv.org/collection/pathology) (722) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1864) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (757) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (787) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (6150) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (10011) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2540) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1524) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1272) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (663) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (805) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (598) * [Surgery](https://www.medrxiv.org/collection/surgery) (806) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (109) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (320) * [Urology](https://www.medrxiv.org/collection/urology) (308) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy
## Related Clinical Research

- [Overall Dietary Patterns Essential for Heart Disease Prevention and Management](https://medichelpline.com/clinical-feed/medical-news-today-0-overall-dietary-pattern-more-important-for-heart-disease-prevention-management.md)
- [Modifiable risk factors linked to vulnerable coronary plaques: OCT study finds 5 drivers](https://medichelpline.com/clinical-feed/medical-news-today-0-5-modifiable-risk-factors-may-fuel-high-risk-plaques-linked-to-heart-attacks.md)
- [Therapeutic patient education reduces one-year major cardiovascular events in Tunisian CHD cohort](https://medichelpline.com/clinical-feed/plos-one-3-evaluation-of-a-therapeutic-education-program-for-patients-with-coronary-heart.md)
- [Cardiovascular risk and mortality after statin initiation: achieved LDL and non‑HDL levels in a 3‑](https://medichelpline.com/clinical-feed/plos-medicine-0-risk-of-cardiovascular-events-and-mortality-associated-with-ldl-and-non-hdl.md)
- [Hypertension prevalence and sex disparities in Sri Lanka: findings from the Sri Lanka STEPS 2021 s](https://medichelpline.com/clinical-feed/plos-one-13-prevalence-associations-and-sex-related-disparities-of-hypertension-in-south.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.